Solid debut! Molbio Diagnostics shares list at 21% premium over IPO price
The listing beat expectations as signalled by the grey market premium (GMP).
Ahead of its debut today, Molbio Diagnostics IPO GMP was ₹120, suggesting 15 per cent listing pop.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.business-standard.com — the content belongs to Business Standard.
